Oral treprostinil improves pulmonary vascular compliance in pulmonary arterial hypertension-Reference-Cited by-同舟云学术

Oral treprostinil improves pulmonary vascular compliance in pulmonary arterial hypertension

Published:2022-03 Issue: Volume:193 Page:106744
ISSN:0954-6111
Container-title:Respiratory Medicine
language:en
Short-container-title:Respiratory Medicine

Author:

Khan Akram^ORCID,White R. James^ORCID,Meyer Gisela,Pulido Zamudio Tomas R.,Jerjes-Sanchez Carlos^ORCID,Johnson Dana^ORCID,Grover Rob,Broderick Meredith,Ousmanou Aliou,Holdstock Louis^ORCID,Michelakis Evangelos

Funder

United Therapeutics Corp

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference16 articles.

1. Combination therapy with oral treprostinil for pulmonary arterial hypertension. A double-blind placebo-controlled clinical trial;White;Am. J. Respir. Crit. Care,2019

2. Transition from parenteral to oral treprostinil in pulmonary arterial hypertension;Chakinala;J. Heart Lung Transplant.,2017

3. Treatment with oral treprostinil Improves hemodynamics in participants with PAH;White,2020

4. Binding and activity of the prostacyclin receptor (IP) agonists, treprostinil and iloprost, at human prostanoid receptors: treprostinil is a potent DP1 and EP2 agonist;Whittle;Biochem. Pharmacol.,2012

5. IP receptor-dependent activation of PPARγ by stable prostacyclin analogues;Falcetti;Biochem. Biophys. Res. Commun.,2007

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Practical management of oral treprostinil in patients with pulmonary arterial hypertension: Lessons from ADAPT, EXPEDITE, and expert consensus;Respiratory Medicine;2024-09

2. Gaps in evidence in the treatment of prevalent patients with pulmonary arterial hypertension at intermediate risk: An expert consensus;Vascular Pharmacology;2024-09

3. Escalating Oral Treprostinil Dose With Intravenous Treprostinil Bridging Therapy;Cureus;2024-02-14

4. Comparison of treprostinil and oral sildenafil for the treatment of persistent pulmonary hypertension of the newborn: a retrospective cohort study;Frontiers in Pediatrics;2023-11-03

5. Safety and efficacy of transitioning from selexipag to oral treprostinil in pulmonary arterial hypertension: Findings from the ADAPT registry;Pulmonary Pharmacology & Therapeutics;2023-10